You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 15, 2024

TAZIDIME IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Tazidime In Plastic Container, and when can generic versions of Tazidime In Plastic Container launch?

Tazidime In Plastic Container is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in TAZIDIME IN PLASTIC CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tazidime In Plastic Container

A generic version of TAZIDIME IN PLASTIC CONTAINER was approved as ceftazidime by ACS DOBFAR on November 20th, 1985.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TAZIDIME IN PLASTIC CONTAINER?
  • What are the global sales for TAZIDIME IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for TAZIDIME IN PLASTIC CONTAINER?
Summary for TAZIDIME IN PLASTIC CONTAINER
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 42
DailyMed Link:TAZIDIME IN PLASTIC CONTAINER at DailyMed
Drug patent expirations by year for TAZIDIME IN PLASTIC CONTAINER

US Patents and Regulatory Information for TAZIDIME IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly TAZIDIME IN PLASTIC CONTAINER ceftazidime INJECTABLE;INJECTION 062739-001 Jul 10, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly TAZIDIME IN PLASTIC CONTAINER ceftazidime INJECTABLE;INJECTION 062739-002 Jul 10, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.